Pneumatic Vitreolysis for the Treatment of Vitreomacular Traction Syndrome
To evaluate the posterior vitreous release rates after a single injection of expansile gas in patients with vitreomacular traction (VMT) syndrome with or without associated full-thickness macular hole (FTMH). Thirteen eyes of 12 consecutive patients with VMT (11 eyes) or VMT+FTMH (2 eyes) were revie...
Uloženo v:
| Vydáno v: | Turk oftalmoloji gazetesi Ročník 49; číslo 4; s. 201 - 208 |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Turkey
Galenos Yayinevi Tic. Ltd
01.08.2019
Türk Oftalmoloji Derneği Galenos Publishing House Turkish Ophthalmology Society |
| Témata: | |
| ISSN: | 1300-0659, 2149-8709, 2147-2661, 2149-8709 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | To evaluate the posterior vitreous release rates after a single injection of expansile gas in patients with vitreomacular traction (VMT) syndrome with or without associated full-thickness macular hole (FTMH).
Thirteen eyes of 12 consecutive patients with VMT (11 eyes) or VMT+FTMH (2 eyes) were reviewed retrospectively. Intravitreal injection of 0.3 mL of pure sulfur hexafluoride (SF6) (9 eyes) or perfluoropropane (C3F8) (4 eyes) was performed. Bobbing the head forward and backward similar to ‘drinking bird’ head movements was instructed until VMT release. Full ophthalmic examination and optical coherence tomography was performed at each visit.
VMT was released in all patients (100%) and mean release time was 5.2 days (1-19 days). Macular hole closure was not achieved in either of the two eyes with FTMH. Mean central subfield thickness decreased significantly from 361 μm to 263 μm (p=0.007). The mean pretreatment visual acuity was 0.44 LogMAR, which significantly improved to 0.25 LogMAR at the last visit (p=0.003). One of 13 eyes had retinal tear after the procedure which was successfully treated with laser retinopexy. Gas migration to the anterior chamber occurred in one patient. No other complications were observed.
Pneumatic vitreolysis with C3F8 and SF6 gases is a relatively safe, low-cost, and minimally invasive treatment modality for VMT. However, FTMH closure could not be achieved with pneumatic vitreolysis. |
|---|---|
| AbstractList | Objectives: To evaluate the posterior vitreous release rates after a single injection of expansile gas in patients with vitreomacular
traction (VMT) syndrome with or without associated full-thickness macular hole (FTMH).
Materials and Methods: Thirteen eyes of 12 consecutive patients with VMT (11 eyes) or VMT+FTMH (2 eyes) were reviewed
retrospectively. Intravitreal injection of 0.3 mL of pure sulfur hexafluoride (SF6) (9 eyes) or perfluoropropane (C3F8) (4 eyes) was
performed. Bobbing the head forward and backward similar to ‘drinking bird’ head movements was instructed until VMT release. Full
ophthalmic examination and optical coherence tomography was performed at each visit.
Results: VMT was released in all patients (100%) and mean release time was 5.2 days (1-19 days). Macular hole closure was not achieved
in either of the two eyes with FTMH. Mean central subfield thickness decreased significantly from 361 μm to 263 μm (p=0.007). The
mean pretreatment visual acuity was 0.44 LogMAR, which significantly improved to 0.25 LogMAR at the last visit (p=0.003). One of
13 eyes had retinal tear after the procedure which was successfully treated with laser retinopexy. Gas migration to the anterior chamber
occurred in one patient. No other complications were observed.
Conclusion: Pneumatic vitreolysis with C3F8 and SF6 gases is a relatively safe, low-cost, and minimally invasive treatment modality
for VMT. However, FTMH closure could not be achieved with pneumatic vitreolysis. To evaluate the posterior vitreous release rates after a single injection of expansile gas in patients with vitreomacular traction (VMT) syndrome with or without associated full-thickness macular hole (FTMH). Thirteen eyes of 12 consecutive patients with VMT (11 eyes) or VMT+FTMH (2 eyes) were reviewed retrospectively. Intravitreal injection of 0.3 mL of pure sulfur hexafluoride (SF6) (9 eyes) or perfluoropropane (C3F8) (4 eyes) was performed. Bobbing the head forward and backward similar to ‘drinking bird’ head movements was instructed until VMT release. Full ophthalmic examination and optical coherence tomography was performed at each visit. VMT was released in all patients (100%) and mean release time was 5.2 days (1-19 days). Macular hole closure was not achieved in either of the two eyes with FTMH. Mean central subfield thickness decreased significantly from 361 μm to 263 μm (p=0.007). The mean pretreatment visual acuity was 0.44 LogMAR, which significantly improved to 0.25 LogMAR at the last visit (p=0.003). One of 13 eyes had retinal tear after the procedure which was successfully treated with laser retinopexy. Gas migration to the anterior chamber occurred in one patient. No other complications were observed. Pneumatic vitreolysis with C3F8 and SF6 gases is a relatively safe, low-cost, and minimally invasive treatment modality for VMT. However, FTMH closure could not be achieved with pneumatic vitreolysis. Objectives: To evaluate the posterior vitreous release rates after a single injection of expansile gas in patients with vitreomacular traction (VMT) syndrome with or without associated full-thickness macular hole (FTMH). Materials and Methods: Thirteen eyes of 12 consecutive patients with VMT (11 eyes) or VMT+FTMH (2 eyes) were reviewed retrospectively. Intravitreal injection of 0.3 mL of pure sulfur hexafluoride (SF6) (9 eyes) or perfluoropropane (C3F8) (4 eyes) was performed. Bobbing the head forward and backward similar to ‘drinking bird’ head movements was instructed until VMT release. Full ophthalmic examination and optical coherence tomography was performed at each visit. Results: VMT was released in all patients (100%) and mean release time was 5.2 days (1-19 days). Macular hole closure was not achieved in either of the two eyes with FTMH. Mean central subfield thickness decreased significantly from 361 μm to 263 μm (p=0.007). The mean pretreatment visual acuity was 0.44 LogMAR, which significantly improved to 0.25 LogMAR at the last visit (p=0.003). One of 13 eyes had retinal tear after the procedure which was successfully treated with laser retinopexy. Gas migration to the anterior chamber occurred in one patient. No other complications were observed. Conclusion: Pneumatic vitreolysis with C3F8 and SF6 gases is a relatively safe, low-cost, and minimally invasive treatment modality for VMT. However, FTMH closure could not be achieved with pneumatic vitreolysis. To evaluate the posterior vitreous release rates after a single injection of expansile gas in patients with vitreomacular traction (VMT) syndrome with or without associated full-thickness macular hole (FTMH).ObjectivesTo evaluate the posterior vitreous release rates after a single injection of expansile gas in patients with vitreomacular traction (VMT) syndrome with or without associated full-thickness macular hole (FTMH).Thirteen eyes of 12 consecutive patients with VMT (11 eyes) or VMT+FTMH (2 eyes) were reviewed retrospectively. Intravitreal injection of 0.3 mL of pure sulfur hexafluoride (SF6) (9 eyes) or perfluoropropane (C3F8) (4 eyes) was performed. Bobbing the head forward and backward similar to ‘drinking bird’ head movements was instructed until VMT release. Full ophthalmic examination and optical coherence tomography was performed at each visit.Materials and MethodsThirteen eyes of 12 consecutive patients with VMT (11 eyes) or VMT+FTMH (2 eyes) were reviewed retrospectively. Intravitreal injection of 0.3 mL of pure sulfur hexafluoride (SF6) (9 eyes) or perfluoropropane (C3F8) (4 eyes) was performed. Bobbing the head forward and backward similar to ‘drinking bird’ head movements was instructed until VMT release. Full ophthalmic examination and optical coherence tomography was performed at each visit.VMT was released in all patients (100%) and mean release time was 5.2 days (1-19 days). Macular hole closure was not achieved in either of the two eyes with FTMH. Mean central subfield thickness decreased significantly from 361 μm to 263 μm (p=0.007). The mean pretreatment visual acuity was 0.44 LogMAR, which significantly improved to 0.25 LogMAR at the last visit (p=0.003). One of 13 eyes had retinal tear after the procedure which was successfully treated with laser retinopexy. Gas migration to the anterior chamber occurred in one patient. No other complications were observed.ResultsVMT was released in all patients (100%) and mean release time was 5.2 days (1-19 days). Macular hole closure was not achieved in either of the two eyes with FTMH. Mean central subfield thickness decreased significantly from 361 μm to 263 μm (p=0.007). The mean pretreatment visual acuity was 0.44 LogMAR, which significantly improved to 0.25 LogMAR at the last visit (p=0.003). One of 13 eyes had retinal tear after the procedure which was successfully treated with laser retinopexy. Gas migration to the anterior chamber occurred in one patient. No other complications were observed.Pneumatic vitreolysis with C3F8 and SF6 gases is a relatively safe, low-cost, and minimally invasive treatment modality for VMT. However, FTMH closure could not be achieved with pneumatic vitreolysis.ConclusionPneumatic vitreolysis with C3F8 and SF6 gases is a relatively safe, low-cost, and minimally invasive treatment modality for VMT. However, FTMH closure could not be achieved with pneumatic vitreolysis. Objectives: To evaluate the posterior vitreous release rates after a single injection of expansile gas in patients with vitreomacular traction (VMT) syndrome with or without associated full-thickness macular hole (FTMH). Materials and Methods: Thirteen eyes of 12 consecutive patients with VMT (11 eyes) or VMT+FTMH (2 eyes) were reviewed retrospectively. Intravitreal injection of 0.3 mL of pure sulfur hexafluoride (SF6) (9 eyes) or perfluoropropane (C3F8) (4 eyes) was performed. Bobbing the head forward and backward similar to 'drinking bird' head movements was instructed until VMT release. Full ophthalmic examination and optical coherence tomography was performed at each visit. Results: VMT was released in all patients (100%) and mean release time was 5.2 days (1-19 days). Macular hole closure was not achieved in either of the two eyes with FTMH. Mean central subfield thickness decreased significantly from 361 [micro]m to 263 [micro]m (p=0.007). The mean pretreatment visual acuity was 0.44 LogMAR, which significantly improved to 0.25 LogMAR at the last visit (p=0.003). One of 13 eyes had retinal tear after the procedure which was successfully treated with laser retinopexy. Gas migration to the anterior chamber occurred in one patient. No other complications were observed. Conclusion: Pneumatic vitreolysis with C3F8 and SF6 gases is a relatively safe, low-cost, and minimally invasive treatment modality for VMT. However, FTMH closure could not be achieved with pneumatic vitreolysis. Keywords: Vitreomacular traction, macular hole, pneumatic vitreolysis, SF6, C3F8 |
| Audience | Academic |
| Author | Özdemir, Hüseyin Baran Hasanreisoğlu, Murat Özdek, Şengül |
| AuthorAffiliation | Oftalmoloji Anabilim Dalı Cerrahi Tıp Bilimleri Bölümü, Göz Hastalıkları Anabilim Dalı Oftalmoloji Kliniği |
| AuthorAffiliation_xml | – name: Oftalmoloji Anabilim Dalı – name: Oftalmoloji Kliniği – name: Cerrahi Tıp Bilimleri Bölümü, Göz Hastalıkları Anabilim Dalı |
| Author_xml | – sequence: 1 fullname: Hasanreisoglu, Murat – sequence: 1 fullname: Ozdemir, Huseyin Baran – sequence: 1 fullname: Ozdek, Sengul |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31486607$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFklFvFCEQxzemxl5rv0KziYn6ciewu7Akvlxqq2cu0cTqK2HZoceFhRbYh_v2sr2ztY2J8EAy_P7DzPA_KY6cd1AU5xgtasLqD2nrFzfSgvNxQRDmC4RqhF4UM4JrNieU4qNihiuE5og2_Lg4i3GL8mpIy2jzqjiucN1Sitis-PrdwTjIZFT5y6QA3u6iiaX2oUwbKK8DyDSAS6XXB2CQarQy5CupkvGu_LFzffADvC5eamkjnB3O0-Ln1eX1xZf5-tvn1cVyPVe0atNcIcw61daUIMAI10AaLSstJcEa943qmpoD6ziDHmtCKOI9qLaXnMqea8DVabHa5-293IrbYAYZdsJLI-4DPtwIGXJDFgTvK8VYleWqqpXCvGPQNQ2nGmpVEZpzvd_nug3-boSYxGCiAmulAz9GQUjb5CKrFmX0zTN068fgcqcTxVDNUMsz9W5PmR6k9c4aB4_g6tPlci14Sxv6mG_6SWGc9ilPdHpeLCmirEGsajO1-AeVdw-DUdkW2uT4E8HbvwSbXETaRG_H6aviU_D80M_YDdA_DPKPNzJA94AKPsYA-gHBSEw-FNmH4uBDMflQ3PswCz8-EyqT5FRArt3Y_8l_Azxh5HA |
| CitedBy_id | crossref_primary_10_1186_s40942_023_00472_x crossref_primary_10_1016_j_pdpdt_2023_103741 crossref_primary_10_1186_s40942_022_00376_2 crossref_primary_10_1007_s40278_019_71779_1 crossref_primary_10_1007_s10792_025_03591_6 crossref_primary_10_1007_s00417_022_05568_y |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2019 Galenos Yayinevi Tic. Ltd. 2019. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: COPYRIGHT 2019 Galenos Yayinevi Tic. Ltd. – notice: 2019. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IEBAR 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 DOA |
| DEWEY | 617.7/TÜR |
| DOI | 10.4274/tjo.galenos.2019.00400 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Idealonline online kütüphane - Journals ProQuest Central (Corporate) ProQuest_Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Publicly Available Content Database MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2147-2661 2149-8709 |
| Editor | İrkeç,Murat |
| Editor_xml | – sequence: 1 fullname: İrkeç,Murat |
| EndPage | 208 |
| ExternalDocumentID | oai_doaj_org_article_9d3c773c8dc34cc19b7eb5596fe4c326 IDEAL_98656 A606750738 31486607 10_4274_tjo_galenos_2019_00400 |
| Genre | Journal Article |
| GeographicLocations | İstanbul Türkiye |
| GeographicLocations_xml | – name: İstanbul – name: Türkiye |
| GroupedDBID | 5VS 7X7 88E 8FI 8FJ AAWTL AAYXX ABUWG AFFHD AFKRA AHMBA ALMA_UNASSIGNED_HOLDINGS BAIFH BBTPI BENPR BPHCQ BVXVI CCPQU CITATION FYUFA GJB GROUPED_DOAJ HMCUK IAO IEA IEBAR IHR IHW ITC KQ8 M1P OK1 PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PV9 RZL SW3 UKHRP ABDBF CGR CUY CVF ECM EIF ESX HYE M48 NPM RPM ALIPV EBD EOJEC OBODZ TUS IPNFZ RIG 3V. 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 |
| ID | FETCH-LOGICAL-c638t-c017bc84620e1014e25fa3faa21f1d5cb549e7b97ed1f22609dec8da96ad9fe13 |
| IEDL.DBID | BENPR |
| ISICitedReferencesCount | 5 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000484381700006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1300-0659 2149-8709 |
| IngestDate | Mon Nov 03 22:02:47 EST 2025 Thu Jul 10 23:10:47 EDT 2025 Sat Nov 29 14:35:42 EST 2025 Fri Nov 21 15:28:07 EST 2025 Tue Nov 11 10:12:36 EST 2025 Tue Nov 04 17:29:12 EST 2025 Thu May 22 21:21:51 EDT 2025 Thu Jan 02 22:59:52 EST 2025 Tue Nov 18 21:54:26 EST 2025 Sat Nov 29 04:26:38 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | macular hole pneumatic vitreolysis SF6 Vitreomacular traction C3F8 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c638t-c017bc84620e1014e25fa3faa21f1d5cb549e7b97ed1f22609dec8da96ad9fe13 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-5585-253X 0000-0002-7494-4106 0000-0001-9885-5653 |
| OpenAccessLink | https://www.proquest.com/docview/2287047089?pq-origsite=%requestingapplication% |
| PMID | 31486607 |
| PQID | 2287047089 |
| PQPubID | 2037338 |
| PageCount | 8 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_9d3c773c8dc34cc19b7eb5596fe4c326 proquest_miscellaneous_2285101380 proquest_journals_2287047089 idealonline_journals_IDEAL_98656 gale_infotracmisc_A606750738 gale_infotracacademiconefile_A606750738 gale_healthsolutions_A606750738 pubmed_primary_31486607 crossref_primary_10_4274_tjo_galenos_2019_00400 crossref_citationtrail_10_4274_tjo_galenos_2019_00400 |
| PublicationCentury | 2000 |
| PublicationDate | 2019-08-01 |
| PublicationDateYYYYMMDD | 2019-08-01 |
| PublicationDate_xml | – month: 08 year: 2019 text: 2019-08-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Turkey |
| PublicationPlace_xml | – name: Turkey – name: Istanbul |
| PublicationTitle | Turk oftalmoloji gazetesi |
| PublicationTitleAlternate | Turk J Ophthalmol |
| PublicationYear | 2019 |
| Publisher | Galenos Yayinevi Tic. Ltd Türk Oftalmoloji Derneği Galenos Publishing House Turkish Ophthalmology Society |
| Publisher_xml | – name: Galenos Yayinevi Tic. Ltd – name: Türk Oftalmoloji Derneği – name: Galenos Publishing House – name: Turkish Ophthalmology Society |
| SSID | ssj0000528765 ssj0001742068 |
| Score | 2.1330986 |
| Snippet | To evaluate the posterior vitreous release rates after a single injection of expansile gas in patients with vitreomacular traction (VMT) syndrome with or... Objectives: To evaluate the posterior vitreous release rates after a single injection of expansile gas in patients with vitreomacular traction (VMT) syndrome... Objectives: To evaluate the posterior vitreous release rates after a single injection of expansile gas in patients with vitreomacular traction (VMT) syndrome... Objectives:To evaluate the posterior vitreous release rates after a single injection of expansile gas in patients with vitreomacular traction (VMT) syndrome... |
| SourceID | doaj proquest idealonline gale pubmed crossref |
| SourceType | Open Website Aggregation Database Index Database Enrichment Source |
| StartPage | 201 |
| SubjectTerms | Adhesion Aged Aged, 80 and over Birds C3F8 Cataracts Diabetes Diabetic retinopathy Edema Endotamponade - methods FDA approval Female Fluorides Fluorocarbons - administration & dosage Humans Intravitreal Injections macular hole Male Market entry Middle Aged Ocriplasmin Ophthalmology Patients pneumatic vitreolysis Povidone Retinal Diseases - surgery Retinal Perforations - surgery Retrospective Studies SF6 Sulfur Sulfur compounds Sulfur hexafluoride Sulfur Hexafluoride - administration & dosage Tıp Tomography Tomography, Optical Coherence Visual Acuity Vitreomacular traction Vitreous Detachment - surgery |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQxQEOqIivhQJGQuIUdhMn_jgu0ApQVVWiVL1ZjjOWFkGCttn-fmZsb9g9oF64xhNLfp6x38ieZ8beKiXlgqp7WkwOitqLunC4MxRBgzQeXOmilNLlqTo701dX5nznqS-6E5bkgRNwc9MJr5TwusN-vC9Nq6BFGiwDYM9VFNtG1rOTTCVVb8wE4juSdFxT0OFhKg-uMQubjz-G97T-9gMJdpekWFlTidvOzhQF_Kdl-v6qQ9qWtCv-TUXjlnRyyB5kLsmXaQwP2R3oH7Gv5z1sog4rv1yNaxii5ghHbsqR6_GL7cVyPoRs8MvFu6jYlIoc-LesYvCYfT85vvj4ucgPJhQew2gsPIZX65FRVAugN3ihaoITwbmqDGXX-BaTQVCtUdCVAXnXwnSAwDojXWcClOIJO-iHHp4xDjS5jRRdiwylDY0BLZykEmiNFEfqGWu2YFmf1cTpUYufFrMKAtkiyDaDbAlkG0Gesfn03--kp3HrHx9oLiZr0sOOH9BLbPYSe5uXzNhr6tmm4tIpqu1SUsaEyxwO6F20oLjGgXiXyxMQDlLI2rM82rPEePR7zXzHW2xeEq7tl0_Hy1NrNBJo7GHrQn_bKzpyrtVCmxl7MzVT53QNrodhE21oDRUaUXmaXG_CRWBii3Gnnv8PvF6wezQD6abjETsY1xt4ye76m3F1vX4VY-0Pfw8seQ priority: 102 providerName: Directory of Open Access Journals |
| Title | Pneumatic Vitreolysis for the Treatment of Vitreomacular Traction Syndrome |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/31486607 http://www.idealonline.com.tr/IdealOnline/lookAtPublications/paperDetail.xhtml?uId=98656 https://www.proquest.com/docview/2287047089 https://www.proquest.com/docview/2285101380 https://doaj.org/article/9d3c773c8dc34cc19b7eb5596fe4c326 |
| Volume | 49 |
| WOSCitedRecordID | wos000484381700006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2147-2661 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000528765 issn: 1300-0659 databaseCode: DOA dateStart: 20150101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVPQU databaseName: Health & Medical Complete (ProQuest Database) customDbUrl: eissn: 2147-2661 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000528765 issn: 1300-0659 databaseCode: 7X7 dateStart: 20150101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2147-2661 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000528765 issn: 1300-0659 databaseCode: BENPR dateStart: 20150101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 2147-2661 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000528765 issn: 1300-0659 databaseCode: PIMPY dateStart: 20150101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELbolgMceAgoC2UJEhKnsHn6cUJb2IqidhVBqZaT5Tg2WgRJyWb5_cw43rR7AA5ccojHlux5eMb2fEPIS8YojTC7p4TgIMx0moUKdobQckOFNipWDkrp4pQtFny5FIU_cFv7Z5Vbm-gMddVoPCOfJngjl7GIizeXP0OsGoW3q76Exh7ZR6SybET2j-aL4uNwyhLl0M3Vk8RrmxAvEfs04QyisWn3rXmNdrhuELg7RuTKDFPdru1QDsh_MNe3VxW4bz2GxZ9dUrc1Hd_930ndI3e8UxrMeim6T2507QPyoajNxgG6BherrjWNAy8JwMkNwGkMzrcv1IPGeoIfyj1qhaY-WyL45OEQHpLPx_Pzt-9DX3kh1KCPXahBT0sNrkkSGSzma5LcqtQqlcQ2rnJdQlRpWCmYqWILDlwkKqN5pQRVlbAmTh-RUd3U5jEJDEpJTtOqBFentLkwPFUUc6k5-EqUj0m-XW2pPSw5Vsf4LiE8QS5J4JL0XJLIJem4NCbTod9lD8zxzx5HyMyBGoG13Y-m_Sq9nkpRpZqxFCYDYqt1LEpmSoi6qDUgyAkdk-c4suyzVAfzIGcUQy-wlzChV44CDQRMRCuf5wDLgVBbO5SHO5Sg2HqnObgmbtLblrU8eTefnUrBwROHEbZyddV-JVRj8mJoxsHxPV1tmo2jQWOccliVg152h3VJIUIGBWZP_j74U3IL17Z_DHlIRl27Mc_ITf2rW63bCdljS-a-fOKVcuLOO-C7KM7gX3FyVnz5DZMQQOs |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEF6VFAk48BCPBgo1EoiTiZ_7OCAUaKuGplEkQlVOy3q9roIgLo4D4k_xG5lZr93mAJx64Oodr-z1Ny_vzjeEPGOM0gCrezJIDvxEx4mvwDP4BTdUaKNCZamUjsdsMuEnJ2K6QX61tTB4rLK1idZQ56XGf-SDCHfkEhZw8frsm49do3B3tW2h0cDi0Pz8ASnb8tVoF77v8yja35u9PfBdVwFfA9ZqXwMGMw1uNwoMNqo1UVqouFAqCoswT3UGGZNhmWAmDwsITgKRG81zJajKRWHCGOa9QjYTADvvkc3p6Gj6sfurE6TwmLZ_JW4T-bhp2ZQlJ5D9DerP5Uu0-4sSicJDZMpMsLTugke0jQM693BjnkO42HBm_DkEtq5w_9b_toi3yU0XdHvDRkvukI26ukveTRdmZQlrveN5XZnSkrN4EMR7EBR7s_YEvlcWTuCrsod2YaipBvHeO7qHe-TDpTz-fdJblAuzRTyDWpDSOM8glMuKVBgeK4q14hxiQcr7JG2_rtSOdh27f3yRkH4hKiSgQjpUSESFtKjok0F331lDPPLPO94geDppJA63F8rqVDo7JEUea8ZieBlQS61DkTGTQVZJCwOKGtE-2cGZZVOF25k_OaSYWoI_gBd6YSXQAMKLaOXqOGA5kEpsTXJ7TRIMl14b9i7AWzrbuZSj3b3hWAoOmQbM0OL4fPwcxH3ytBvGyfG84MKUKyuDzibmsCoPGl3p1iUOEw4Gij38--Q75NrB7Ggsx6PJ4SNyHde5Ofi5TXp1tTKPyVX9vZ4vqyfOCHjk02WrzG9mJJpm |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9QwFLZKixAcWMQ2UGiQQJzCZPVyQGhgOmLoMIpEqcrJOI6DBsGkZDIg_hq_jvccJ-0cgFMPXOMXK3a-t9lvIeQxY5QGmN2Tg3PgJzpOfAWawS-5oUIbFSpbSuloxuZzfnwssi3yq8uFwbDKTiZaQV1UGs_IhxHeyCUs4GJYurCIbDx5cfLNxw5SeNPatdNoIXJgfv4A9231fDqGf_0kiib7h69e-67DgK8Bd42vAY-5BhUcBQab1pooLVVcKhWFZVikOgfvybBcMFOEJRgqgSiM5oUSVBWiNGEM814gO2CSJ8BjO9n0bfahP-EJUvhk28sSr4x8vMBsU5QT8ASHzefqGeqAZYVFw0Osmplgmt0Z7WibCPSq4sqiANOxrZ_xZ3PYqsXJtf95Q6-Tq84Y90Yt99wgW019k7zJlmZtC9l6R4umNpUt2uKBce-BsewddpH5XlU6gq_KBvPCUJsl4r1zZSBukffn8vm3yfayWpq7xDPIHSmNixxMvLxMheGxophDzsFGpHxA0u5PS-3KsWNXkC8S3DJEiASESIcQiQiRFiEDMuzfO2kLkvzzjZcIpJ4aC4rbB1X9STr5JEURa8ZiWAywq9ahyJnJwdukpQEGjuiA7OHMss3O7cWiHFF0OUFPwIKeWgoUjLAQrVx-B2wHlhjboNzdoASBpjeGvTNQl06mruR0vD-aScHBA4EZOkyfjp8CekAe9cM4OcYRLk21tjSohGIOu3Kn5Zt-X-Iw4SC42L2_T75HLgGfyNl0fnCfXMZtbuNBd8l2U6_NA3JRf28Wq_qhkwce-XjeHPMbjl-jJg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pneumatic+vitreolysis+for+the+treatment+of+vitreomacular+traction+syndrome&rft.jtitle=Turk+oftalmoloji+gazetesi&rft.au=%C3%96zdemir%2CH%C3%BCseyin+Baran&rft.au=%C3%96zdek%2C%C5%9Eeng%C3%BCl&rft.au=Hasanreiso%C4%9Flu%2CMurat&rft.date=2019-08-01&rft.pub=T%C3%BCrk+Oftalmoloji+Derne%C4%9Fi&rft.issn=1300-0659&rft.eissn=2147-2661&rft.volume=49&rft.issue=4&rft.spage=201&rft.epage=208&rft_id=info:doi/10.4274%2Ftjo.galenos.2019.00400&rft.externalDBID=n%2Fa&rft.externalDocID=IDEAL_98656 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1300-0659&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1300-0659&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1300-0659&client=summon |